Adagene Company Top Insiders

ADAG Stock  USD 1.75  0.06  3.55%   
Adagene employs about 138 people. The company is managed by 13 executives with a total tenure of roughly 322 years, averaging almost 24.0 years of service per executive, having 10.62 employees per reported executive. Examination of Adagene's management performance can provide insight into the company performance.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adagene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more detail on how to invest in Adagene Stock please use our How to Invest in Adagene guide.

Adagene Management Team Effectiveness

The company has return on total asset (ROA) of (0.2192) % which means that it has lost $0.2192 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5521) %, meaning that it created substantial loss on money invested by shareholders. Adagene's management efficiency ratios could be used to measure how well Adagene manages its routine affairs as well as how well it operates its assets and liabilities.

Adagene Workforce Comparison

Adagene is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 413. Adagene totals roughly 138 in number of employees claiming about 33% of equities under Health Care industry.

Adagene Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Adagene Price Series Summation is a cross summation of Adagene price series and its benchmark/peer.

Adagene Notable Stakeholders

An Adagene stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Adagene often face trade-offs trying to please all of them. Adagene's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Adagene's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Peter LuoChairman, FounderProfile
Alexander GoergenVP DevelopmentProfile
Songmao ZhengVP PharmacologyProfile
Jiping MDExecutive DevelopmentProfile
Man MBACFO DirectorProfile
Guizhong LiuHead PharmacologyProfile
Xiaohong SheSenior OperationsProfile
Ling ZhouExecutive ResourcesProfile
Qinghai ZhaoChief OfficerProfile
Fangyong DuChief OfficerProfile
Ami KnoeflerVice CommunicationsProfile
Yan MBASenior TechnologyProfile
Jc MDChief OfficerProfile

About Adagene Management Performance

The success or failure of an entity such as Adagene often depends on how effective the management is. Adagene management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Adagene management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Adagene management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company was incorporated in 2011 and is headquartered in Suzhou, China. Adagene Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 259 people.

Adagene Workforce Analysis

Traditionally, organizations such as Adagene use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Adagene within its industry.

Adagene Manpower Efficiency

Return on Adagene Manpower

Revenue Per Employee748
Revenue Per Executive7.9K
Net Loss Per Employee242.2K
Net Loss Per Executive2.6M
Working Capital Per Employee359.4K
Working Capital Per Executive3.8M

Complementary Tools for Adagene Stock analysis

When running Adagene's price analysis, check to measure Adagene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adagene is operating at the current time. Most of Adagene's value examination focuses on studying past and present price action to predict the probability of Adagene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adagene's price. Additionally, you may evaluate how the addition of Adagene to your portfolios can decrease your overall portfolio volatility.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios